Sep 24, 2025 | Feature, National
President Donald Trump’s pick to be the White House’s top drug policy adviser refrained from endorsing a proposed rule to reclassify cannabis from a Schedule I to Schedule III drug under the Controlled Substances Act. That abstention was, in part, because her likely...
Sep 24, 2025 | Feature, Great Lakes Region, Michigan
On Tuesday, September 16, the Chairman of Michigan’s House Regulatory Reform Committee, Representative Joseph Aragona, introduced a package of bills to address two significant problems confronting Michigan’s cannabis industry—licensees defaulting on payments and...